石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01093 石药集团

休市中 05-29 16:08:26

7.500

+0.540

+7.76%

最高7.520	最低6.940	成交量2.35亿
今开6.960	昨收6.960	日振幅8.33%
总市值864.15亿	流通市值864.15亿	总股本115.22亿
成交额17.36亿	换手率2.04%	流通股本115.22亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01093","market":"HK","secType":"STK","nameCN":"石药集团","latestPrice":7.5,"timestamp":1780042106002,"preClose":6.96,"halted":0,"volume":235149836,"delay":0,"changeRate":0.07758620689655173,"floatShares":11522000000,"shares":11522000000,"eps":0.3937201918480263,"marketStatus":"休市中","change":0.54,"latestTime":"05-29 16:08:26","open":6.96,"high":7.52,"low":6.94,"amount":1735593856,"amplitude":0.083333,"askPrice":7.5,"askSize":5278000,"bidPrice":7.49,"bidSize":1416000,"shortable":3,"etf":0,"ttmEps":0.33134717346259046,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780277400000},"marketStatusCode":7,"adr":0,"listingDate":772128000000,"exchange":"SEHK","adjPreClose":6.96,"dividendRate":0.032013,"openAndCloseTimeList":[[1780018200000,1780027200000],[1780030800000,1780041600000]],"volumeRatio":1.824281448317825,"optionData":{"bulkOrders":[{"symbol":"CSP.HK","call":false,"expireDate":1782662400000,"strike":"7.50","timestamp":1780032590799,"price":0.53,"volume":261,"amount":276660,"type":"*"},{"symbol":"CSP.HK","call":false,"expireDate":1787846400000,"strike":"6.75","timestamp":1780032187340,"price":0.41,"volume":225,"amount":184500,"type":"*"}]},"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"CSP.HK","impliedVol":0.4952,"impliedVolPercentile":0.3008},"requestUrl":"/m/hq/s/01093/tweets","defaultTab":"tweets","newsList":[{"id":"2639627307","title":"石药集团(01093)：收到阿斯利康就创新长效多肽药物开发的战略合作与授权协议项下的12亿美元首付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2639627307","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639627307?lang=zh_cn&edition=full","pubTime":"2026-05-29 20:19","pubTimestamp":1780057161,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团(01093)发布公告，内容有关集团与阿斯利康签订战略研发合作与授权协议(该协议)。集团与阿斯利康签订该协议，以利用集团所拥有的长效递送技术平台及多肽药物AI发现平台，开发创新长效多肽药物，并将根据该协议条款(其中包括)收取12亿美元的首付款。董事会欣然宣布，集团已于2026年5月29日(交易时间后)收到上述阿斯利康支付的首付款12亿美元。该首付款的收取将为集团的财务状况带来正面贡献。目前，双方的合作进展顺利。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447988.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","LU1226288253.USD","LU0315179316.USD","LU0889565916.HKD","LU1008478684.HKD","LU1328277881.USD","AZN","IE0008368742.USD","LU2417539215.USD","LU1226288170.HKD","LU0067412154.USD","BK4007","LU0880133367.SGD","LU0289739699.SGD","IE0008369823.USD","LU2462157665.USD","LU0109394709.USD","LU2237443465.HKD","01093","IE00B031HY20.USD","LU0501845795.SGD","LU0072913022.USD","LU1152091168.USD","BK4568","LU1829250122.USD","BK4585","LU2039709279.SGD","LU2237443382.USD","LU0058720904.USD","LU0314109678.HKD","LU1152091754.HKD","IE00BZ08YR35.GBP","LU1807302812.USD","BK1515","LU2237443622.USD","LU2236285917.USD","LU0140636845.USD","LU2237443978.SGD","AZNH","IE00BZ08YS42.EUR","BK1521","LU2237443895.HKD","BK4588","LU2456880835.USD","LU1226287875.USD","LU0326950275.SGD","LU1960683339.HKD","LU1226287792.SGD","LU1813983027.USD","LU1226287529.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639231436","title":"石药集团(01093)：恩尼妥®(安尼妥单抗注射液)获国家药监局批准上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2639231436","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639231436?lang=zh_cn&edition=full","pubTime":"2026-05-29 17:03","pubTimestamp":1780045405,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，本集团附属公司上海津曼特生物科技有限公司与江苏康宁杰瑞生物制药有限公司合作开发的安尼妥单抗注射液(该产品)已获得中华人民共和国国家药品监督管理局批准上市。该适应症为该产品首个获批上市的适应症。该产品联合HB1801用于一线HER2阳性乳腺癌的关键注册III期临床研究结果预计在今年公布。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447759.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1226287529.USD","BK1521","LU1807302812.USD","LU0501845795.SGD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","LU1152091754.HKD","LU1226287792.SGD","LU1152091168.USD","SG9999004220.SGD","IE00B543WZ88.USD","LU0315179316.USD","LU0326950275.SGD","LU1226288253.USD","LU1813983027.USD","LU0140636845.USD","IE00BZ08YT58.USD","IE00B5MMRT66.SGD","LU1008478684.HKD","IE00B031HY20.USD","BK1191","LU0067412154.USD","HK0000165453.HKD","IPOS","LU0314109678.HKD","LU1226287875.USD","LU1960683339.HKD","01093","LU0072913022.USD","LU1951186391.HKD","IE0008368742.USD","LU0880133367.SGD","IE0008369823.USD","LU1328277881.USD","BK1515","LU2039709279.SGD","LU1993786604.SGD","LU1226288170.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176833686","title":"异动解读 | 大行上调目标价叠加业绩回弹，石药集团盘中大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=1176833686","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176833686?lang=zh_cn&edition=full","pubTime":"2026-05-29 14:15","pubTimestamp":1780035345,"startTime":"0","endTime":"0","summary":"石药集团今日盘中大涨5.17%，引起了市场的广泛关注。消息面上，多家大行发布积极研报是推动股价上涨的主要动力。摩根士丹利将石药集团目标价上调至11港元，并维持“增持”评级，报告指出其国内产品销售似乎已恢复正增长，且过往及潜在的业务拓展交易有望释放持续的授权费收入。此外，有市场分析指出，石药集团2026年第一季度业绩显示其成药销售重回增长轨道，业绩显现触底回升信号。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131429732","title":"港股异动｜创新药概念股拉升，信达生物涨近13%，石药集团、荣昌生物涨7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131429732","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131429732?lang=zh_cn&edition=full","pubTime":"2026-05-29 13:44","pubTimestamp":1780033481,"startTime":"0","endTime":"0","summary":"诺诚健华涨超5%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"14627b4c07acfccfc4c1fb81226a69da","theme_name":"热榜No.19 · 港股生物醫藥股集體上漲 信達生物領漲9%","theme_type":2,"isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093","09969","01801","09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639490246","title":"石药集团一季报爆雷背后：净利润骤降41.8％，传统引擎熄火后，老牌药企如何破局？","url":"https://stock-news.laohu8.com/highlight/detail?id=2639490246","media":"华夏时报网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639490246?lang=zh_cn&edition=full","pubTime":"2026-05-29 13:37","pubTimestamp":1780033044,"startTime":"0","endTime":"0","summary":"伴随石药集团一季报出炉，投资者残存的期待被彻底浇灭。5月27日午间，石药集团发布2026年第一季度未经审核业绩，营业收入64.65亿元，同比减少7.8%；归母净利润8.60亿元，同比大幅下降41.8%。午后开盘股价随即跳水，盘中一度跌超10%，最终收报7.04港元/股，跌幅5.38%。仅一个下午，市值蒸发约70亿港元，跌破850亿港元关口。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605293754207771.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605293754207771.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149340096","title":"异动解读｜石药集团盘中上涨3.3%，大摩上调目标价叠加超跌反弹提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1149340096","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149340096?lang=zh_cn&edition=full","pubTime":"2026-05-29 11:29","pubTimestamp":1780025369,"startTime":"0","endTime":"0","summary":"5月29日，石药集团盘中上涨3.3%，报7.18港元/股，成交额2.46亿港元。公司股价在此前因一季度净利润同比下滑41.8%而连续承压后，今日出现反弹。消息面上，摩根士丹利发布研报维持\"增持\"评级，目标价由10.4港元上调至11港元，指出国内产品销售似乎恢复正增长，BD交易有望释放持续授权费收入。中金同日维持\"跑赢行业\"评级，目标价12港元。此外，公司近期密集获批布地奈德肠溶胶囊、兰索拉唑肠溶胶囊等多款新药，产品管线持续丰富，为估值修复提供基本面支撑。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639457576","title":"成药销售重回增长，石药集团业绩回弹信号显现","url":"https://stock-news.laohu8.com/highlight/detail?id=2639457576","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639457576?lang=zh_cn&edition=full","pubTime":"2026-05-29 11:28","pubTimestamp":1780025280,"startTime":"0","endTime":"0","summary":"2026年第一季度，石药集团（01093）经营业绩呈现结构性分化态势，受去年创新药对外授权高基数的影响，整体营收、净利润同比承压。但剔除一次性授权收益后，公司核心成药业务出现回暖、基本面持续修复。随着集采负面冲击逐步出清、创新管线价值持续释放，公司正步入传统主业企稳复苏、创新业务持续兑现的关键转折期。创新研发层面，石药集团在多赛道居国内第一梯队，兼备技术壁垒与全球化实力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605293754124951.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE0008368742.USD","LU1951186391.HKD","IE00B5MMRT66.SGD","BK1515","LU1226288253.USD","LU1008478684.HKD","IE00BZ08YS42.EUR","IE00B031HY20.USD","LU1226287792.SGD","01093","LU1226287529.USD","IE00B543WZ88.USD","LU1960683339.HKD","LU1152091168.USD","LU0067412154.USD","LU0501845795.SGD","LU0326950275.SGD","HK0000165453.HKD","LU0140636845.USD","LU0880133367.SGD","BK1521","LU0315179316.USD","LU0072913022.USD","IE00BZ08YR35.GBP","IE0008369823.USD","LU1152091754.HKD","IE00BZ08YT58.USD","LU1226288170.HKD","LU2039709279.SGD","SG9999004220.SGD","LU0314109678.HKD","LU1813983027.USD","LU1328277881.USD","BK1191","LU1807302812.USD","LU1993786604.SGD","LU1226287875.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639878645","title":"大华继显：下调石药集团(01093)目标价至6港元 评级降至“沽出”","url":"https://stock-news.laohu8.com/highlight/detail?id=2639878645","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639878645?lang=zh_cn&edition=full","pubTime":"2026-05-29 11:05","pubTimestamp":1780023910,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，大华继显发布研报称，石药集团(01093)第一季业绩显著差过该行及市场预期，将目标价由8.8港元下调至6港元，评级降至“沽出”，以反映相当大的政策风险。该行表示，石药致力实现产品销售正增长，并预期2026年起授权费收入将带动利润率上升，但该行担心反腐监管趋严，以及新的销售与宣传规则，可能会令其药品销售增长前景变得不明朗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447577.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01093","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639643271","title":"大摩：上调石药集团(01093)目标价至11港元 维持“增持”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2639643271","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639643271?lang=zh_cn&edition=full","pubTime":"2026-05-29 10:50","pubTimestamp":1780023032,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，摩根士丹利发布研报称，石药集团(01093)发布第一季度业绩后，维持正面看法，并在报告指，国内产品销售似乎终于恢复正增长，而过往 BD (业务拓展)交易合作及潜在新 BD 交易有望释放持续的授权费收入，维持“增持”评级，目标价由10.4港元上调至11港元。大摩上调石药2026年每股盈利预测123%，以反映大部分与阿斯利康的协议带来的预付款，及以前未入账到2026年的预付款，但亦指出无论实际现金收取时间如何，BD 收入账的时间点仍存在固有的不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447569.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EWH","01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639061000","title":"中金：维持石药集团(01093)跑赢行业评级 目标价12港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2639061000","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639061000?lang=zh_cn&edition=full","pubTime":"2026-05-29 09:27","pubTimestamp":1780018037,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中金发布研报称，考虑对外授权收入确认节奏变化，下调石药集团2026年净利润17.6%至75.03亿元，上调2027年净利润72.2%至78.56亿元当前股价对应2026/2027年9.3倍/8.7倍市盈率。中金主要观点如下：1Q26业绩符合市场预期公司公布1Q26业绩：收入64.65亿元，同比下滑7.8%;归母净利润8.60亿元，同比下滑41.8%，经调整净利润8.42亿元，同比下滑40.3%，符合市场预期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447524.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EWH","01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638608546","title":"石药集团一季度净利同比跌超40%，授权费收入下滑拖累业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2638608546","media":"红星资本局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638608546?lang=zh_cn&edition=full","pubTime":"2026-05-28 19:08","pubTimestamp":1779966498,"startTime":"0","endTime":"0","summary":"红星资本局5月28日消息，5月27日，石药集团（1093.HK）发布2026年一季报。一季度该公司收入64.65亿元，同比下降7.8%；归母净利润8.59亿元，同比下降41.8%。受该消息影响，当日公司股价一度跌超10%。5月28日，其股价继续下探，截至收盘，股价跌1.14%，报6.96港元/股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605283752928725.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1521","LU0314109678.HKD","IE00BZ08YT58.USD","LU0067412154.USD","IE00B031HY20.USD","LU1960683339.HKD","IE0008369823.USD","BK1515","IE00B5MMRT66.SGD","LU1813983027.USD","LU0315179316.USD","IE0008368742.USD","IE00BZ08YS42.EUR","BK1191","01093","LU1226287875.USD","LU0880133367.SGD","SG9999004220.SGD","LU1152091168.USD","HK0000165453.HKD","LU1226288170.HKD","LU1226287529.USD","LU2039709279.SGD","LU0072913022.USD","LU1008478684.HKD","LU1993786604.SGD","LU1328277881.USD","LU1807302812.USD","LU0501845795.SGD","IE00B543WZ88.USD","LU1226288253.USD","IE00BZ08YR35.GBP","LU1951186391.HKD","LU0140636845.USD","LU1226287792.SGD","LU1152091754.HKD","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638651262","title":"业绩持续承压 石药集团一季度归母净利润下降超四成","url":"https://stock-news.laohu8.com/highlight/detail?id=2638651262","media":"经济参考网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638651262?lang=zh_cn&edition=full","pubTime":"2026-05-28 12:16","pubTimestamp":1779941813,"startTime":"0","endTime":"0","summary":"5月27日，石药集团有限公司(简称“石药集团”，01093.HK)发布2026年一季报，当期实现收入64.65亿元，同比减少7.8%；归母净利润8.60亿元，同比大幅下降41.8%，剔除去年同期高基数授权费影响后，净利润同比减少7.3%，业绩延续了此前的承压态势。作为国内医药行业龙头，今年一季度石药集团的成药、原料药、功能食品三大业务板块呈现明显分化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605283752537868.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107474221","title":"异动解读｜石药集团盘中上涨3.27%，超跌反弹叠加近期多款新药获批提振信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1107474221","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107474221?lang=zh_cn&edition=full","pubTime":"2026-05-28 09:53","pubTimestamp":1779933202,"startTime":"0","endTime":"0","summary":"5月28日，石药集团盘中上涨3.27%，报7.25港元/股，成交额2.78亿港元。公司股价在前一交易日因一季度净利润同比下滑41.8%而大跌近8%后，今日出现技术性反弹。消息面上，公司近期密集获批多款新药，包括乌司奴单抗注射液、布地奈德肠溶胶囊及兰索拉唑肠溶胶囊，产品管线持续丰富。此外，瑞银此前将公司评级上调至\"买入\"，目标价10.9港元，认为其AI药物研发领先地位尚未充分反映在估值中，当前股价与目标价存在较大空间，为市场情绪提供一定支撑。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638576371","title":"石药集团(01093)午后跳水跌近8% 首季股东溢利同比减少41.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638576371","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638576371?lang=zh_cn&edition=full","pubTime":"2026-05-27 13:11","pubTimestamp":1779858708,"startTime":"0","endTime":"0","summary":"金吾财讯 | 石药集团(01093)午后股价跳水，截至发稿，报6.86港元，跌7.8%，成交额4.8亿港元。集团午间发布公告公布，截至2026年3月31日止三个月，公司拥有人应占溢利8.60亿元(人民币，下同)，同比减少41.83%；每股基本盈利7.54分。期内，集团收入64.65亿元，同比减少7.83%。期内，集团毛利42.68亿元，同比减少9.28%。成药业务收入52.24亿元，同比减少5%；原料产品业务收入7.96亿元，同比减少25.7%；功能食品及其他收入4.45亿元，同比增长0.5%。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/NDQ1MWJhN2NhODAzMzgwYTAyY2UxMDMzODA5NjE3NDc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NDQ1MWJhN2NhODAzMzgwYTAyY2UxMDMzODA5NjE3NDc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"bb201425e904a805589fcede8d542e15","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1982321","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","LU0315179316.USD","IE0008369823.USD","LU1226287875.USD","IE00BZ08YT58.USD","LU0072913022.USD","LU1152091754.HKD","LU1807302812.USD","LU1226287529.USD","LU1951186391.HKD","01093","BK1521","LU0067412154.USD","LU0140636845.USD","LU1226287792.SGD","BK1191","IE00BZ08YS42.EUR","IE00B543WZ88.USD","LU0501845795.SGD","LU1008478684.HKD","LU1960683339.HKD","LU2039709279.SGD","SG9999004220.SGD","LU1328277881.USD","IE0008368742.USD","LU0314109678.HKD","BK1515","LU0326950275.SGD","IE00BZ08YR35.GBP","LU1226288170.HKD","LU1813983027.USD","HK0000165453.HKD","IE00B031HY20.USD","LU1993786604.SGD","LU1152091168.USD","LU0880133367.SGD","LU1226288253.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143539710","title":"异动解读 | 石药集团盘中大跌5.11%，首季业绩下滑及评级遭下调拖累股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1143539710","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143539710?lang=zh_cn&edition=full","pubTime":"2026-05-27 13:03","pubTimestamp":1779858204,"startTime":"0","endTime":"0","summary":"石药集团今日盘中股价大幅下挫5.11%，引发市场关注。消息面上，公司于今日盘前及盘中时段发布了2026年第一季度业绩报告。业绩下滑主要由于去年同期录得较高的授权费收入，若撇除该影响，股东应占溢利仍同比减少7.3%。此外，招商证券在业绩发布后，将石药集团的投资评级下调至“中性”，并调低了目标价，指出其肿瘤业务表现不及预期，且市场对业务发展的预期已被消化。多重负面因素叠加，导致公司股价在今日交易时段内承压下行。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"bb201425e904a805589fcede8d542e15","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180481899","title":"异动解读｜石药集团盘中下跌4.3%，Q1净利润同比下降41.8%叠加招商证券下调评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1180481899","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180481899?lang=zh_cn&edition=full","pubTime":"2026-05-27 13:01","pubTimestamp":1779858106,"startTime":"0","endTime":"0","summary":"5月27日，石药集团盘中下跌4.3%，报7.12港元/股，成交额2.8亿港元。消息面上，公司当日披露第一季度业绩，期内实现营收64.65亿元人民币，同比下降7.8%；归母净利润8.60亿元，同比下降41.8%，主要受去年同期较高授权费收入基数影响。撇除授权费后，净利润仍下滑7.3%。此外，招商证券将石药集团评级下调至中性，目标价降至9.3港元，指出肿瘤业务不及预期且BD预期已被市场消化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"bb201425e904a805589fcede8d542e15","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150794544","title":"石药集团公布第一季度净利润85.98亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1150794544","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150794544?lang=zh_cn&edition=full","pubTime":"2026-05-27 12:26","pubTimestamp":1779855981,"startTime":"0","endTime":"0","summary":"石药集团（CSPC Pharmaceutical Group）发布第一季度业绩报告，期内归属于公司所有者的净利润达到85.98亿元人民币。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1226287529.USD","BK1521","LU1807302812.USD","LU0501845795.SGD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","LU1152091754.HKD","LU1226287792.SGD","LU1152091168.USD","SG9999004220.SGD","IE00B543WZ88.USD","LU0315179316.USD","LU0326950275.SGD","LU1226288253.USD","LU1813983027.USD","LU0140636845.USD","IE00BZ08YT58.USD","IE00B5MMRT66.SGD","LU1008478684.HKD","IE00B031HY20.USD","BK1191","LU0067412154.USD","HK0000165453.HKD","LU0314109678.HKD","LU1226287875.USD","LU1960683339.HKD","01093","LU0072913022.USD","LU1951186391.HKD","IE0008368742.USD","LU0880133367.SGD","IE0008369823.USD","LU1328277881.USD","BK1515","LU2039709279.SGD","LU1993786604.SGD","LU1226288170.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638815575","title":"石药集团(01093)第一季度股东应占呈报溢利8.60亿元 同比减少41.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638815575","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638815575?lang=zh_cn&edition=full","pubTime":"2026-05-27 12:17","pubTimestamp":1779855425,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团(01093)发布2026年第一季度业绩，本集团于本期取得收入人民币64.65亿元，同比减少7.8%;本公司股东应占呈报溢利人民币8.60亿元，同比减少41.8%;每股盈利人民币7.54分。公告称，本期呈报溢利按年减少，主要是由于去年同期取得较高的授权费收入。若撇除授权费收入的影响，本期本公司股东应占呈报溢利为人民币7.36亿元，较去年同期减少7.3%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"bb201425e904a805589fcede8d542e15","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446462.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0008368742.USD","IE00B031HY20.USD","LU1328277881.USD","SG9999004220.SGD","LU0315179316.USD","HK0000165453.HKD","LU1960683339.HKD","LU0314109678.HKD","IE00B5MMRT66.SGD","LU0072913022.USD","LU1951186391.HKD","LU0140636845.USD","IE00BZ08YS42.EUR","LU0501845795.SGD","LU1993786604.SGD","LU1807302812.USD","LU1152091168.USD","LU0880133367.SGD","LU1226288253.USD","LU1226287792.SGD","LU0067412154.USD","LU0326950275.SGD","LU1226287875.USD","IE00BZ08YR35.GBP","LU1226288170.HKD","IE0008369823.USD","LU2039709279.SGD","LU1008478684.HKD","LU1813983027.USD","IE00B543WZ88.USD","01093","LU1226287529.USD","BK1521","BK1191","BK1515","LU1152091754.HKD","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638575555","title":"石药集团：第一季度营收64.7亿元，同比下降7.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638575555","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638575555?lang=zh_cn&edition=full","pubTime":"2026-05-27 12:14","pubTimestamp":1779855267,"startTime":"0","endTime":"0","summary":"石药集团：第一季度营收64.7亿元，同比下降7.8%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605273751023939.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":"bb201425e904a805589fcede8d542e15","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605273751023939.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169612115","title":"石药集团2026年第一季度营收64.65亿元，经调整净利润8.42亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169612115","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169612115?lang=zh_cn&edition=full","pubTime":"2026-05-27 12:11","pubTimestamp":1779855076,"startTime":"0","endTime":"0","summary":"石药集团公告显示，2026年第一季度实现营收64.65亿元，同比下降7.8%。经调整净利润为8.42亿元，同比下降40.3%。本季度研发投入14.03亿元，较上年同期增长7.7%，占成药业务收入的26.8%。成药业务实现收入52.24亿元，同比下降5.0%。原料产品业务收入7.96亿元，同比下降25.7%，主要由于维生素C及抗生素类价格下行。功能食品及其他板块收入4.45亿元，同比增长0.5%，主要受咖啡因产品销售收入稳定增长带动。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"石药集团2026年第一季度营收64.65亿元，经调整净利润8.42亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cspc.com.hk","stockEarnings":[{"period":"1week","weight":-0.0247},{"period":"1month","weight":-0.1029},{"period":"3month","weight":-0.2424},{"period":"6month","weight":-0.0518},{"period":"1year","weight":0.0123},{"period":"ytd","weight":-0.1103}],"compareEarnings":[{"period":"1week","weight":-0.0165},{"period":"1month","weight":-0.0356},{"period":"3month","weight":-0.0544},{"period":"6month","weight":-0.0262},{"period":"1year","weight":0.0683},{"period":"ytd","weight":-0.0175}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"石药集团有限公司是一家主要从事药品生产和销售的投资控股公司。该公司以“石药”品牌销售其产品。该公司包括四个业务部门：成药部门、抗生素（中间体及原料药）部门、维生素C（原料药）部门及咖啡因及其他（原料药）部门，分别从事生产及销售相关药品业务。该公司的成药包括抗生素、心脑血管用药、糖尿病用药、精神神经用药、抗肿瘤用药及中医药产品。该公司还通过其子公司从事提供药品研发服务及污水及药物副产品处理业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.53125,"avgChangeRate":0.009625},{"month":2,"riseRate":0.75,"avgChangeRate":0.094687},{"month":3,"riseRate":0.46875,"avgChangeRate":0.017323},{"month":4,"riseRate":0.59375,"avgChangeRate":0.057765},{"month":5,"riseRate":0.59375,"avgChangeRate":0.04257},{"month":6,"riseRate":0.322581,"avgChangeRate":0.003636},{"month":7,"riseRate":0.375,"avgChangeRate":0.009082},{"month":8,"riseRate":0.4375,"avgChangeRate":0.010009},{"month":9,"riseRate":0.5,"avgChangeRate":0.000153},{"month":10,"riseRate":0.5625,"avgChangeRate":0.010484},{"month":11,"riseRate":0.46875,"avgChangeRate":0.00638},{"month":12,"riseRate":0.5,"avgChangeRate":-0.013271}],"exchange":"SEHK","name":"石药集团","nameEN":"CSPC PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"石药集团,01093,石药集团股票,石药集团股票老虎,石药集团股票老虎国际,石药集团行情,石药集团股票行情,石药集团股价,石药集团股市,石药集团股票价格,石药集团股票交易,石药集团股票购买,石药集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}